Description
Snap-8 overview
Snap-8, also known as acetyl octapeptide-3, is an eight-amino-acid peptide modelled on the N-terminal end of SNAP-25, a protein in the SNARE complex. It is used mainly in cosmetic science and SNARE-complex research.
Protides Health lists Snap-8 10mg in 10mg for laboratory research. The specification table below sets out the contents, molecular data and storage conditions, and the certificate of analysis is shown in the image gallery or linked in the product summary. You can compare related compounds in our research peptides collection.
Snap-8 Peptide Specifications
| Property | Details |
|---|---|
| Product Contents | Snap-8 10mg Lyophilized Powder (99% purity) in 3mL vial. |
| Available Sizes | 10mg |
| Peptide Type | Synthetic acetylated octapeptide (8 amino acids, SNARE complex-targeting sequence) |
| Purity | 99% (HPLC-MS verified, third-party tested) |
| Molecular Formula | C41H70N16O16S |
| Molecular Weight | 1075.16 g/mol |
| Sequence | Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH₂ |
| CAS Number | 868844-74-0 |
| CID | 86080331 |
| Synonyms | SNAP-8, Snap 8, Snap8, Acetyl Octapeptide-3, Acetyl-Octapeptide-3, INCI Acetyl Octapeptide-3 |
| Appearance | White to off-white lyophilized powder in sealed glass vial |
| Storage | Store at ≤6°C, sealed, away from heat, light, and moisture. |
| Solubility | Soluble in water |
Snap-8 chemical structure
Two- and three-dimensional structures, identifiers and literature references are available from the U.S. National Library of Medicine’s PubChem database: PubChem CID 86080331.
Legal Disclaimer: Snap-8 is sold by Protides Health, an independent retailer that is not affiliated with Protide Health, for laboratory research purposes only. This product is not approved by the FDA for human consumption, medical use, or veterinary use. By completing a purchase, you verify that you are a qualified researcher and must comply with applicable local, state, and federal regulations. Please review our Research Use Policy before purchasing.
Reviews
There are no reviews yet.